Erste Asset Management Gmb H Exact Sciences Corp Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

A detailed history of Erste Asset Management Gmb H transactions in Exact Sciences Corp stock. As of the latest transaction made, Erste Asset Management Gmb H holds 392,139 shares of EXAS stock, worth $23.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

392,139

Holding current value

$23.8 Million

% of portfolio

0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $16.6 Million - $27.8 Million	392,139 New	392,139 $26.5 Billion
Q2 2024 Nov 26, 2024	SELL	$41.33 - $74.26 $735,508 - $1.32 Million	-17,796 Reduced 5.49%	306,132 $13 Billion
Q1 2024 Nov 26, 2024	BUY	$56.27 - $73.77 $2.31 Million - $3.02 Million	41,000 Added 14.49%	323,928 $22.3 Billion
Q4 2023 Nov 26, 2024	BUY	$59.06 - $75.72 $1.48 Million - $1.89 Million	25,000 Added 9.69%	282,928 $21 Billion
Q3 2023 Nov 26, 2024	SELL	$65.94 - $99.04 $6.66 Million - $10 Million	-100,950 Reduced 28.13%	257,928 $17.6 Billion
Q2 2023 Nov 26, 2024	SELL	$62.68 - $95.05 $2.21 Million - $3.35 Million	-35,212 Reduced 11.43%	272,790 $25.6 Billion
Q1 2023 Nov 26, 2024	SELL	$47.19 - $70.77 $706,481 - $1.06 Million	-14,971 Reduced 4.64%	308,002 $20.8 Billion
Q4 2022 Nov 26, 2024	BUY	$30.35 - $53.15 $2.09 Million - $3.66 Million	68,931 Added 23.77%	358,878 $17.8 Billion
Q3 2022 Nov 26, 2024	SELL	$31.97 - $49.37 $2.21 Million - $3.41 Million	-69,166 Reduced 17.64%	322,973 $10.5 Billion
Q2 2022 Nov 26, 2024	BUY	$35.61 - $76.23 $6.52 Million - $14 Million	183,147 Added 171.49%	289,947 $11.5 Billion
Q1 2022 Nov 22, 2024	BUY	$57.56 - $82.54 $1.59 Million - $2.28 Million	27,600 Added 17.7%	183,500 $12.9 Billion
Q4 2021 Nov 22, 2024	SELL	$72.5 - $100.68 $12.3 Million - $17.1 Million	-170,239 Reduced 43.41%	221,900 $17.2 Billion
Q3 2021 Nov 22, 2024	BUY	$90.24 - $124.05 $4.06 Million - $5.58 Million	45,000 Added 40.58%	155,900 $14.8 Billion
Q2 2021 Nov 22, 2024	BUY	$93.66 - $139.27 $1.4 Million - $2.09 Million	15,000 Added 15.64%	110,900 $13.9 Billion
Q1 2021 Nov 22, 2024	SELL	$116.57 - $155.01 $4.43 Million - $5.89 Million	-38,000 Reduced 28.38%	95,900 $12.5 Billion
Q4 2020 Nov 22, 2024	SELL	$99.61 - $142.12 $1.14 Million - $1.62 Million	-11,400 Reduced 7.85%	133,900 $18.1 Billion
Q3 2020 Nov 22, 2024	SELL	$72.92 - $102.01 $18 Million - $25.2 Million	-246,839 Reduced 62.95%	145,300 $14.8 Billion
Q1 2020 Nov 22, 2024	BUY	$37.9 - $104.44 $2.05 Million - $5.64 Million	54,000 Added 81.45%	120,300 $6.99 Billion
Q4 2019 Nov 22, 2024	SELL	$77.66 - $99.74 $25.3 Million - $32.5 Million	-325,839 Reduced 83.09%	66,300 $6.17 Billion
Q3 2019 Nov 22, 2024	SELL	$90.37 - $122.49 $1.08 Million - $1.47 Million	-12,000 Reduced 10.73%	99,800 $9.1 Billion
Q1 2019 Nov 22, 2024	SELL	$61.98 - $96.5 $17.4 Million - $27.1 Million	-280,339 Reduced 71.49%	111,800 $9.58 Billion
Q4 2018 Nov 26, 2024	SELL	$56.04 - $82.66 $16 Million - $23.6 Million	-285,339 Reduced 72.76%	106,800 $6.51 Billion

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Exact Sciences Corp Transaction History